Growth Failure
40
1
7
16
Key Insights
Highlights
Success Rate
84% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
7.5%
3 terminated out of 40 trials
84.2%
-2.3% vs benchmark
5%
2 trials in Phase 3/4
31%
5 of 16 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 16 completed trials
Clinical Trials (40)
Increlex Treatment of Children With Chronic Liver Disease and Short Stature
Early Protein Supplementation in Extremely Preterm Infants Fed Human Milk
SMOF Lipid for Children With Parenteral Nutrition Induced Liver Injury
Impact of Colostrum Oropharyngeal Immunotherapy on Postnatal Growth in Preterm Infants
Targeted Fortification of Donor Breast Milk in Preterm Infants
Is There a Microbiome Associated With Poor Growth in Preterm Infants?
A Cohort Study of the Intestinal Microbiota of Premature Infants
Targeted Fortification of Pasteurized Donor Human Milk
Prophylactic Probiotics to Extremely Low Birth Weight Prematures
Nutritional Stimulation of Growth in Children With Short Stature
Environmental Enteropathy Among Infants and Children With Growth Faltering
Growth Faltering Intervention Using Pediatric Nutritional Care (PNC) vs.PNC& FSMP
Randomized Clinical Trial of Two Different Initial Growth Hormone Doses in Children
Human Milk Fortification With Adjustable Versus Targeted Method
Nutritional Impact of Moringa Oleifera Leaf Supplementation in Mothers and Children
Enteral Zinc to Improve Growth in Infants at Risk for Bronchopulmonary Dysplasia
The Effect of Early Versus Standard Central Line Removal on Growth of Very Low Birth Weight Premature Infants
Preterm Infants on Early Solid Foods
The PREWEAN Study. Weaning of Preterm Infants During the First Year of Life.
MAL-ED Metabolic: A Follow-Up of Chronic Disease at Puberty